Archive · 24 Jul 2025
Mounjaro vs. Wegovy in India: Diabetes and Weight Loss
Imagine your body has a sugar problem, and you need help.
Mounjaro and Wegovy are like special helpers.
Mounjaro works in two ways to lower sugar and help you lose weight, while Wegovy works in one way, mainly for weight loss.
Mounjaro seems better at lowering sugar and helping people lose weight faster.
Both can cause tummy troubles.
In India, Mounjaro might be a better deal.
Always talk to your doctor before using any medication.
Mounjaro and Wegovy are medications for managing type 2 diabetes, but they work differently.
Mounjaro uses a dual-action mechanism (GLP-1 and GIP), while Wegovy uses GLP-1 only.
Mounjaro is more effective at lowering blood sugar and promoting weight loss compared to Wegovy.
Both medications have similar side effects, including nausea, diarrhea, and headaches.
Mounjaro may be more cost-effective than Wegovy in India, offering better value for diabetic patients.
- Who
- Individuals with type 2 diabetes.
- What
- Comparison of Mounjaro and Wegovy medications.
- When
- Recent years.
- Where
- India.
- Why
- To provide a comparison of the two medications for diabetes control and weight loss.
Mounjaro Benefits
Wegovy Benefits
Effectiveness
Mounjaro Benefits
Mounjaro provides better blood sugar control.
Wegovy Benefits
Wegovy is better for weight loss for non-diabetic individuals.
Cost and Availability
Mounjaro Benefits
Mounjaro is more cost-effective in India.
Wegovy Benefits
Wegovy has a longer global track record.
- Mounjaro Mechanism
- GLP-1 and GIP dual-action
- Wegovy Mechanism
- GLP-1 only
- Mounjaro HbA1c reduction
- 1.8% to 2.4%
- Wegovy HbA1c reduction
- 1.0% to 1.5%
- Mounjaro weight loss
- 12% to 15%
- Wegovy weight loss
- 10% to 12%
- Side effects
- Nausea, diarrhea, constipation, headache, fatigue, injection site reactions